Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

Available Structures

52 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal Structure of the Activated FGF Receptor 2 (FGFR2) Kinase Domain in complex with the cSH2 do… Heteromer
P10686;
466-774
ACP;MG;
Assess
CRYSTAL STRUCTURE OF FGF2 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 2… Heteromer
P09038;
150-363
SO4;
Assess
CRYSTAL STRUCTURE OF PRO253ARG APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2 Heteromer
P09038;
150-361
Assess
LIGAND-BINDING PORTION OF FIBROBLAST GROWTH FACTOR RECEPTOR 2 IN COMPLEX WITH FGF1 Heteromer
P05230;
151-362
18×SO4;
Assess
CRYSTAL STRUCTURE OF SER252TRP APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2 Heteromer
P09038;
150-361
Assess
CRYSTAL STRUCTURE OF A TERNARY FGF1-FGFR2-HEPARIN COMPLEX Heteromer
P05230;
149-360
SGN;NI;SO4;
Assess
Crystal Structure of FGF1 complexed with the ectodomain of FGFR2b harboring P253R Apert mutation Heteromer
P05230;
151-361
SO4;
Assess
Crystal structure of FGF1 complexed with the ectodomain of FGFR2b harboring the A172F Pfeiffer synd… Heteromer
P05230;
151-361
SO4;
Assess
Crystal Structure Analysis of the FGF10-FGFR2b Complex Heteromer
O15520;
151-361
SO4;15P;
Assess
Crystal Structure of Fibroblast growth factor (FGF)8b in complex with FGF Receptor (FGFR) 2c Heteromer
P55075;
151-360
Assess
Low resolution crystal structure of the FGFR2D2D3/FGF1/SR128545 complex Heteromer
P05230;
153-360
Assess
Crystal Structure of 2:2:2 FGFR2D2:FGF1:SOS complex Heteromer
P05230;
150-249
GU4;
Assess
Crystal structure of the FGFR2 D2 domain in complex with Fab 2B.1.3 Heteromer
154-251
Assess
Structure of phosphotransferasehomo-4-mer458-768
PO4;M33;
Assess
Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation R…homo-4-mer462-764
SO4;ACP;
Assess
FGFr2 kinase domainhomo-4-mer467-765
SO4;AA2;
Assess
FGFR2 in complex with YJ001homo-4-mer467-765
KX0;CL;
Assess
The FGFr2 tyrosine kinase domainhomo-4-mer467-764
SO4;
Assess
FGFR2 Kinase Domain Bound to Irreversible Inhibitor Cmpd 10homo-2-mer460-765
GOL;UIM;SO4;
Assess
Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domains Trapped in Trans-Phosphorylation Reactionhomo-2-mer468-772
MG;ACP;
Assess
Crystal Structure of Tyrosine Phosphorylated Activated FGF Receptor 2 (FGFR2) Kinase Domain in Comp…homo-2-mer467-770
MG;ACP;
Assess
Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657homo-2-mer466-766
ACP;MG;
Assess
Crystal Structure of Unphosphorylated Unactivated Wild Type FGF Receptor 2 (FGFR2) Kinase Domainhomo-2-mer467-766
SO4;
Assess
Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K641R Mutation R…homo-2-mer467-766
SO4;ACP;
Assess
Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565G Mutation R…homo-2-mer468-766
SO4;MG;ACP;
Assess
Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation R…homo-2-mer468-766
SO4;MG;ACP;
Assess
Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549H Mutation R…homo-2-mer467-765
SO4;ACP;
Assess
Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549T Mutation R…homo-2-mer468-766
SO4;MG;ACP;
Assess
FGFR2 kinase domain in complex with a Pyrazolo[1,5-a]pyrimidine analog (Compound 29)homo-2-mer467-765
U9P;
Assess
Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565A Mutation R…homo-2-mer468-766
SO4;ACP;
Assess
The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffoldhomo-2-mer467-764
9WX;
Assess
Crystal Structure of hFGFR2 D2 Domainhomo-2-mer150-249
Assess
Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring an E565A/K659M Double G…monomer461-766
FLC;SO4;
Assess
Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function…monomer461-766
SO4;FLC;
Assess
Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659Q Muta…monomer461-764
SO4;
Assess
Discovery and clinical validation of RLY-4008, the first highly selective FGFR2 inhibitor with acti…monomer461-764
WCJ;
Assess
Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 3monomer466-766
WF7;FLC;GOL;
Assess
Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Muta…monomer466-764
SO4;ACP;
Assess
Crystal structure of FGFR2 in complex with 1,3,5-triazine derivativemonomer468-766
EVC;SO4;
Assess
Crystal structure of FGFR2 in complex with 1,3,5-triazine derivativemonomer468-766
SO4;EVL;
Assess
Crystal structure of the catalytic domain of FGFR2 kinase in complex with ARQ 069monomer468-765
3RH;SO4;
Assess
Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound …monomer467-764
WFD;FLC;NA;
Assess
FGFR2 Kinase Domain Bound to Reversible Inhibitor Cmpd 3monomer468-765
GOL;GSH;WXQ;
Assess
Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation R…monomer467-764
ACP;SO4;
Assess
Crystal Structure of FGF Receptor 2 Tyrosine Kinase Domain Harboring the D650V Activating Mutationmonomer468-764
SO4;ANP;
Assess
Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 Harboring a E565A/D650V double Ga…monomer468-764
SO4;ACP;MG;
Assess
Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function…monomer468-764
ACP;SO4;
Assess
FGFR2 kinase domain (residues 461-763) in complex with 38.monomer467-762
47I;SO4;
Assess
Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring a N549H/E565A Double Ga…monomer469-764
SO4;ACP;MG;
Assess
Solution Structure of the D2 Domain of the Fibroblast Growth Factormonomer149-249
Assess
Crystal structure of the FGFR2 D2 domainmonomer150-249
Assess
Crystal structure of D2 domain from human FGFR2monomer151-249
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6v6q.1.Ahomo-2-mer0.76466-766
MG;97.56
Assess
1ry7.1.Bmonomer0.66153-364
59.55
Assess

37 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 27f3m.1.Amonomer0.76467-767
74.76
Assess
Isoform 21ry7.1.Bmonomer0.68153-364
59.55
Assess
Isoform 36v6q.1.Ahomo-2-mer0.76467-767
MG;97.56
Assess
Isoform 31ry7.1.Bmonomer0.63153-362
58.47
Assess
Isoform 44qqt.1.Amonomer0.78378-673
74.75
Assess
Isoform 43ojm.1.Bmonomer0.7162-272
99.56
Assess
Isoform 56v6q.1.Ahomo-2-mer0.76464-764
MG;97.30
Assess
Isoform 51ry7.1.Bmonomer0.67153-364
59.55
Assess
Isoform 66v6q.1.Ahomo-2-mer0.76464-764
MG;94.37
Assess
Isoform 61ry7.1.Bmonomer0.67153-364
59.55
Assess
Isoform 87f3m.1.Amonomer0.76465-765
74.76
Assess
Isoform 81ry7.1.Bmonomer0.67153-364
59.55
Assess
Isoform 145xwt.1.Amonomer0.5645-249
26.37
Assess
Isoform 147ok5.1.Amonomer0.5342-248
30.11
Assess
Isoform 145w21.1.Cmonomer0.5247-251
20.44
Assess
Isoform 141e0o.1.Bmonomer0.5147-249
18.68
Assess
Isoform 156v6q.1.Ahomo-2-mer0.77350-650
MG;97.44
Assess
Isoform 151ry7.1.Bmonomer0.52153-313
60.08
Assess
Isoform 166v6q.1.Ahomo-2-mer0.76467-767
MG;97.30
Assess
Isoform 161ry7.1.Bmonomer0.61153-368
59.05
Assess
Isoform 177f3m.1.Amonomer0.76468-768
74.76
Assess
Isoform 171ry7.1.Bmonomer0.65153-362
54.49
Assess
Isoform 186v6q.1.Ahomo-2-mer0.76465-765
MG;97.30
Assess
Isoform 181ry7.1.Bmonomer0.64153-362
58.47
Assess
Isoform 193ojm.1.Bmonomer0.76151-361
99.10
Assess
Isoform 191e0o.1.Bmonomer0.74153-358
NI;87.62
Assess
Isoform 195xwu.1.Cmonomer0.5545-359
25.18
Assess
Isoform 197ok5.1.Bmonomer0.5349-359
21.25
Assess
Isoform 206v6q.1.Ahomo-2-mer0.77349-649
MG;97.30
Assess
Isoform 201ev2.1.Emonomer0.7435-245
98.61
Assess
Isoform 201e0o.1.Bmonomer0.7236-245
NI;99.07
Assess
Isoform 216v6q.1.Ahomo-2-mer0.77377-677
MG;94.31
Assess
Isoform 214j23.1.Amonomer0.5764-271
100.00
Assess
Isoform 218dfm.1.Bmonomer0.5036-271
31.55
Assess
Isoform 226v6q.1.Ahomo-2-mer0.77378-678
MG;97.18
Assess
Isoform 223ojm.1.Bmonomer0.7262-272
99.56
Assess
Isoform 236v6q.1.Ahomo-2-mer0.77354-654
MG;97.56
Assess